Okay, I will compile a forensic log of material events for KNIP11 (Kinea Índice de Preços FII) from the last 90 days, focusing on facts that alter the asset's risk/reward profile. I will adhere to the specified output requirements.

Based on the search results, here's a forensic log of material events for KNIP11 (Kinea Índice de Preços FII) from the last 90 days:

**No material events detected in the search window.**

While I couldn't find specific "Fato Relevante" filings or news articles detailing legal issues, sell-side rating changes, or operational disruptions within the last 90 days, here's some general information about KNIP11 that may be relevant:

*   **[2025 Retrospective]:** Between January and April 2025, KNIP11's revenue reached R$ 4.66 per share, a 10% year-over-year increase. This was driven by higher inflation, which increased revenue from CRIs by 13% through monetary correction. At the same time, recurring expenses per share decreased by 8%. As a result, the fund recorded a 12% growth in results and a 7% increase in dividend distribution compared to the same period of the previous year.
*   **[Ongoing Analysis]:** XP Investimentos has reiterated its "buy" recommendation for KNIP11. Their analysis points to an experienced and qualified management team, a low-risk credit portfolio with robust guarantees, an attractive carry with a net implied return equivalent to IPCA + 9.64% p.a., and an estimated yield of 12.3% in their base scenario for the next 12 months. They also cite excellent liquidity and lower volatility compared to peers.
*   **[Fund Allocation]:** At the end of December, Kinea Índice de Preços presented an allocation of 103.1% of its assets in target assets and 7.4% in cash instruments. The portion invested in CRI has a rate (MTM) of IPCA + 10.32% p.a. and a duration of 3.8 years.
*   **[General Information]:** KNIP11 is a fixed-income real estate fund from Kinea with a benchmark in real interest rates.

**Disclaimer:** This is based on available search results and may not be exhaustive. Always consult official sources for definitive information.
